
IGF-1 DES
Local IGF, fast acting.
- Sizes available
- 1mg
- Lab certificate (COA)
- Arrives with shipment
· Research-grade only · Not for human consumption · 21+ ·
Truncated IGF-1. Short half-life with strong local action. Site injection.
Mechanism · Des(1-3) IGF-1. N-terminal 3-amino-acid removed variant. Hyperplasia-focused.
Best for. Not for.
Best for
- Site-specific muscle hyperplasia.
- Users on a short (2-week) cycle.
- Post-workout local injection.
Not for
- Hypoglycemia risk.
- Active malignancy, pregnancy, or children.
- Acromegaly or diabetic retinopathy.
Mechanism, dose, ramp, risk.
- Mechanism
- Short-acting IGF analogue. Site-injection for hyperplasia.Source · PEPVERA editorial
- Target dose
- 20-50 mcg, site-specific.Source · PEPVERA editorial
- Ramp
- 2-Week cycle.Source · PEPVERA editorial
- Risks
- Site-specific hypertrophy can imbalance.Source · PEPVERA editorial
Compared to its siblings.
IGF-1 DES
Truncated IGF-1. Short half-life with strong local action. Site injection.
Pros
- · Strong local hyperplasia action via IGFBP bypass.
- · Site-specific targeting unavailable to systemic IGF-1 LR3.
Cons
- · Daily or short-cycle injection burden versus IGF-1 LR3's ~20 hr half-life.
- · Limited human data versus IGF-1 LR3.
IGF-1 LR3
Long half-life (~20 hr). Systemic action.
Pros
- · Less frequent injection
Cons
- · Less site-specific
See IGF-1 LR3 →
MGF (Mechano Growth Factor)
Mechano variant. Exercise-coupled.
Pros
- · Targeted repair
Cons
- · Limited data
See MGF (Mechano Growth Factor) →
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 1 suppliers
| Supplier | Price | COA | Ships | |
|---|---|---|---|---|
| SwissChemsUS | $55.95$55.95/mg · 1mg | COA with shipment | 3 days |
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Risk
Site-specific hypertrophy can imbalance. These pass with discipline. They do not pass with bravado.
Source · PEPVERA editorialDiscipline
2-Week cycle.
Source · PEPVERA editorialWellness
Hydrate. Eat protein. Sleep eight. Hold a dose for at least two weeks before ascending.
Anti-patterns
- · Do not pair with stimulants late in the day.
- · Do not break the cycle without a planned taper.
- · Do not exceed the dose to chase a deeper sleep response.
Crisis
If the ramp triggers severe anxiety, anhedonia, or persistent gastrointestinal disturbance, stop. Resume after two weeks at half the prior dose. The discipline is the slow climb.
Week 1–2
20-50 mcg, site-specific.
Initiation
Week 3–4
20-50 mcg, site-specific.
Signal emerges
Week 5–8
20-50 mcg, site-specific.
Hold
Week 9–12
Cycle review
Assess
Draw 20 units.
0.1 mg = 0.20 mL at 0.50 mg/mL. 10.0 doses per vial.
apex · IX · SwissChems
IGF-1 DES · 1mg